Albemarle Revisited
Since I wrote my article on Albemarle (ALB) in mid-May, I wanted to update my view of the company and its stock. While I still maintain my ALB holding at the same levels, I wanted to present these analysts' viewpoints.
It may well be that short-term COVID-19 effects on ALB will leak into a slightly longer time frame. However, I see no fundamental basis for reconsidering a long-term position. My original article is here.
Downgrade: Goldman Sachs
Albemarle downgraded to Neutral from Buy at Goldman Sachs
“Goldman Sachs analyst Robert Koort downgraded